Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
16.6M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
11.9M
-
Shares change
-
+1.46M
-
Total reported value, excl. options
-
$193M
-
Value change
-
+$27.3M
-
Put/Call ratio
-
3.2
-
Number of buys
-
48
-
Number of sells
-
-37
-
Price
-
$16.18
Significant Holders of RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) as of Q3 2024
108 filings reported holding RIGL - RIGEL PHARMACEUTICALS INC - Common Stock as of Q3 2024.
RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.9M shares
of 16.6M outstanding shares and own 71.59% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1.56M shares), ARMISTICE CAPITAL, LLC (1.54M shares), MORGAN STANLEY (1.46M shares), Invesco Ltd. (1.05M shares), VANGUARD GROUP INC (985K shares), Soleus Capital Management, L.P. (935K shares), Assenagon Asset Management S.A. (442K shares), ACADIAN ASSET MANAGEMENT LLC (422K shares), GEODE CAPITAL MANAGEMENT, LLC (400K shares), and STATE STREET CORP (368K shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.